Search results
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of his...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 5 hours agoWe've identified 1 warning sign for Moderna that investors should be aware of in a dynamic business...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 6 days agoModerna stock is yo-yoing after the company unveiled early-stage test results for its...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 23 hours agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 1 day agoBeyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 6 days agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Ginkgo Bioworks: Buy, Sell, or Hold?
Motley Fool via Yahoo Finance· 42 minutes agoThe core issues are that it's a biotech stock, which makes it risky, and it's pursuing a highly capital-intensive business model that hasn't been proven...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 4 days agoModerna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks· 5 days agoWall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA Quick QuoteMRNA - Free Report) reports results for the quarter ended March 2024 ...
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoReport) by 106.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,626 shares of the company’s stock after buying ...
